Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Delivery Systems. This report contains market size and forecasts of Transdermal Drug Delivery Systems in global, including the following market information:
Global Transdermal Drug Delivery Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Transdermal Drug Delivery Systems market was valued at US$ 15500 million in 2022 and is projected to reach US$ 19260 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
We surveyed the Transdermal Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Drug Delivery Systems Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, by Type, 2022 (%)
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Global Transdermal Drug Delivery Systems Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, by Application, 2022 (%)
OTC
Rx
Global Transdermal Drug Delivery Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Transdermal Drug Delivery Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Drug Delivery Systems revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Transdermal Drug Delivery Systems revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Novartis
Teve (Actavis)
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Drug Delivery Systems, market overview.
Chapter 2: Global Transdermal Drug Delivery Systems market size in revenue.
Chapter 3: Detailed analysis of Transdermal Drug Delivery Systems company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Transdermal Drug Delivery Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal Drug Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal Drug Delivery Systems Overall Market Size
2.1 Global Transdermal Drug Delivery Systems Market Size: 2022 VS 2029
2.2 Global Transdermal Drug Delivery Systems Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Transdermal Drug Delivery Systems Players in Global Market
3.2 Top Global Transdermal Drug Delivery Systems Companies Ranked by Revenue
3.3 Global Transdermal Drug Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Transdermal Drug Delivery Systems Companies in Global Market, by Revenue in 2022
3.5 Global Companies Transdermal Drug Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transdermal Drug Delivery Systems Players in Global Market
3.6.1 List of Global Tier 1 Transdermal Drug Delivery Systems Companies
3.6.2 List of Global Tier 2 and Tier 3 Transdermal Drug Delivery Systems Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Transdermal Drug Delivery Systems Market Size Markets, 2022 & 2029
4.1.2 Fentanyl
4.1.3 Nitroglycerin
4.1.4 Estradiol
4.1.5 Nicotine
4.1.6 Other
4.2 By Type - Global Transdermal Drug Delivery Systems Revenue & Forecasts
4.2.1 By Type - Global Transdermal Drug Delivery Systems Revenue, 2018-2023
4.2.2 By Type - Global Transdermal Drug Delivery Systems Revenue, 2024-2029
4.2.3 By Type - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Transdermal Drug Delivery Systems Market Size, 2022 & 2029
5.1.2 OTC
5.1.3 Rx
5.2 By Application - Global Transdermal Drug Delivery Systems Revenue & Forecasts
5.2.1 By Application - Global Transdermal Drug Delivery Systems Revenue, 2018-2023
5.2.2 By Application - Global Transdermal Drug Delivery Systems Revenue, 2024-2029
5.2.3 By Application - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Transdermal Drug Delivery Systems Market Size, 2022 & 2029
6.2 By Region - Global Transdermal Drug Delivery Systems Revenue & Forecasts
6.2.1 By Region - Global Transdermal Drug Delivery Systems Revenue, 2018-2023
6.2.2 By Region - Global Transdermal Drug Delivery Systems Revenue, 2024-2029
6.2.3 By Region - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Transdermal Drug Delivery Systems Revenue, 2018-2029
6.3.2 US Transdermal Drug Delivery Systems Market Size, 2018-2029
6.3.3 Canada Transdermal Drug Delivery Systems Market Size, 2018-2029
6.3.4 Mexico Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Transdermal Drug Delivery Systems Revenue, 2018-2029
6.4.2 Germany Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.3 France Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.4 U.K. Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.5 Italy Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.6 Russia Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.7 Nordic Countries Transdermal Drug Delivery Systems Market Size, 2018-2029
6.4.8 Benelux Transdermal Drug Delivery Systems Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Transdermal Drug Delivery Systems Revenue, 2018-2029
6.5.2 China Transdermal Drug Delivery Systems Market Size, 2018-2029
6.5.3 Japan Transdermal Drug Delivery Systems Market Size, 2018-2029
6.5.4 South Korea Transdermal Drug Delivery Systems Market Size, 2018-2029
6.5.5 Southeast Asia Transdermal Drug Delivery Systems Market Size, 2018-2029
6.5.6 India Transdermal Drug Delivery Systems Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Transdermal Drug Delivery Systems Revenue, 2018-2029
6.6.2 Brazil Transdermal Drug Delivery Systems Market Size, 2018-2029
6.6.3 Argentina Transdermal Drug Delivery Systems Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Transdermal Drug Delivery Systems Revenue, 2018-2029
6.7.2 Turkey Transdermal Drug Delivery Systems Market Size, 2018-2029
6.7.3 Israel Transdermal Drug Delivery Systems Market Size, 2018-2029
6.7.4 Saudi Arabia Transdermal Drug Delivery Systems Market Size, 2018-2029
6.7.5 UAE Transdermal Drug Delivery Systems Market Size, 2018-2029
7 Transdermal Drug Delivery Systems Companies Profiles
7.1 Hisamitsu
7.1.1 Hisamitsu Company Summary
7.1.2 Hisamitsu Business Overview
7.1.3 Hisamitsu Transdermal Drug Delivery Systems Major Product Offerings
7.1.4 Hisamitsu Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.1.5 Hisamitsu Key News & Latest Developments
7.2 Mylan
7.2.1 Mylan Company Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Transdermal Drug Delivery Systems Major Product Offerings
7.2.4 Mylan Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.2.5 Mylan Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Transdermal Drug Delivery Systems Major Product Offerings
7.3.4 GSK Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Transdermal Drug Delivery Systems Major Product Offerings
7.4.4 Novartis Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Teve (Actavis)
7.5.1 Teve (Actavis) Company Summary
7.5.2 Teve (Actavis) Business Overview
7.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Major Product Offerings
7.5.4 Teve (Actavis) Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.5.5 Teve (Actavis) Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Major Product Offerings
7.6.4 Johnson & Johnson Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Lohmann
7.7.1 Lohmann Company Summary
7.7.2 Lohmann Business Overview
7.7.3 Lohmann Transdermal Drug Delivery Systems Major Product Offerings
7.7.4 Lohmann Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.7.5 Lohmann Key News & Latest Developments
7.8 Teikoku Seiyaku
7.8.1 Teikoku Seiyaku Company Summary
7.8.2 Teikoku Seiyaku Business Overview
7.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Major Product Offerings
7.8.4 Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.8.5 Teikoku Seiyaku Key News & Latest Developments
7.9 Bayer
7.9.1 Bayer Company Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Transdermal Drug Delivery Systems Major Product Offerings
7.9.4 Bayer Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.9.5 Bayer Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Transdermal Drug Delivery Systems Major Product Offerings
7.10.4 Novartis Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Teve (Actavis)
7.11.1 Teve (Actavis) Company Summary
7.11.2 Teve (Actavis) Business Overview
7.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Major Product Offerings
7.11.4 Teve (Actavis) Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.11.5 Teve (Actavis) Key News & Latest Developments
7.12 Qizheng
7.12.1 Qizheng Company Summary
7.12.2 Qizheng Business Overview
7.12.3 Qizheng Transdermal Drug Delivery Systems Major Product Offerings
7.12.4 Qizheng Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.12.5 Qizheng Key News & Latest Developments
7.13 Endo
7.13.1 Endo Company Summary
7.13.2 Endo Business Overview
7.13.3 Endo Transdermal Drug Delivery Systems Major Product Offerings
7.13.4 Endo Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.13.5 Endo Key News & Latest Developments
7.14 Huarun 999
7.14.1 Huarun 999 Company Summary
7.14.2 Huarun 999 Business Overview
7.14.3 Huarun 999 Transdermal Drug Delivery Systems Major Product Offerings
7.14.4 Huarun 999 Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.14.5 Huarun 999 Key News & Latest Developments
7.15 Haw Par
7.15.1 Haw Par Company Summary
7.15.2 Haw Par Business Overview
7.15.3 Haw Par Transdermal Drug Delivery Systems Major Product Offerings
7.15.4 Haw Par Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.15.5 Haw Par Key News & Latest Developments
7.16 Nichiban
7.16.1 Nichiban Company Summary
7.16.2 Nichiban Business Overview
7.16.3 Nichiban Transdermal Drug Delivery Systems Major Product Offerings
7.16.4 Nichiban Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.16.5 Nichiban Key News & Latest Developments
7.17 Mentholatum
7.17.1 Mentholatum Company Summary
7.17.2 Mentholatum Business Overview
7.17.3 Mentholatum Transdermal Drug Delivery Systems Major Product Offerings
7.17.4 Mentholatum Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.17.5 Mentholatum Key News & Latest Developments
7.18 Laboratoires Genevrier
7.18.1 Laboratoires Genevrier Company Summary
7.18.2 Laboratoires Genevrier Business Overview
7.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Major Product Offerings
7.18.4 Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue in Global Market (2018-2023)
7.18.5 Laboratoires Genevrier Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Transdermal Drug Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Transdermal Drug Delivery Systems Market Drivers in Global Market
Table 3. Transdermal Drug Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Transdermal Drug Delivery Systems in Global Market
Table 5. Top Transdermal Drug Delivery Systems Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Transdermal Drug Delivery Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Transdermal Drug Delivery Systems Revenue Share by Companies, 2018-2023
Table 8. Global Companies Transdermal Drug Delivery Systems Product Type
Table 9. List of Global Tier 1 Transdermal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transdermal Drug Delivery Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Transdermal Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Transdermal Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Transdermal Drug Delivery Systems Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Transdermal Drug Delivery Systems Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Transdermal Drug Delivery Systems Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Transdermal Drug Delivery Systems Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2024-2029
Table 30. Hisamitsu Company Summary
Table 31. Hisamitsu Transdermal Drug Delivery Systems Product Offerings
Table 32. Hisamitsu Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 33. Hisamitsu Key News & Latest Developments
Table 34. Mylan Company Summary
Table 35. Mylan Transdermal Drug Delivery Systems Product Offerings
Table 36. Mylan Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 37. Mylan Key News & Latest Developments
Table 38. GSK Company Summary
Table 39. GSK Transdermal Drug Delivery Systems Product Offerings
Table 40. GSK Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 41. GSK Key News & Latest Developments
Table 42. Novartis Company Summary
Table 43. Novartis Transdermal Drug Delivery Systems Product Offerings
Table 44. Novartis Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis Key News & Latest Developments
Table 46. Teve (Actavis) Company Summary
Table 47. Teve (Actavis) Transdermal Drug Delivery Systems Product Offerings
Table 48. Teve (Actavis) Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 49. Teve (Actavis) Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Transdermal Drug Delivery Systems Product Offerings
Table 52. Johnson & Johnson Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Lohmann Company Summary
Table 55. Lohmann Transdermal Drug Delivery Systems Product Offerings
Table 56. Lohmann Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 57. Lohmann Key News & Latest Developments
Table 58. Teikoku Seiyaku Company Summary
Table 59. Teikoku Seiyaku Transdermal Drug Delivery Systems Product Offerings
Table 60. Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 61. Teikoku Seiyaku Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Transdermal Drug Delivery Systems Product Offerings
Table 64. Bayer Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Transdermal Drug Delivery Systems Product Offerings
Table 68. Novartis Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Teve (Actavis) Company Summary
Table 71. Teve (Actavis) Transdermal Drug Delivery Systems Product Offerings
Table 72. Teve (Actavis) Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 73. Teve (Actavis) Key News & Latest Developments
Table 74. Qizheng Company Summary
Table 75. Qizheng Transdermal Drug Delivery Systems Product Offerings
Table 76. Qizheng Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 77. Qizheng Key News & Latest Developments
Table 78. Endo Company Summary
Table 79. Endo Transdermal Drug Delivery Systems Product Offerings
Table 80. Endo Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 81. Endo Key News & Latest Developments
Table 82. Huarun 999 Company Summary
Table 83. Huarun 999 Transdermal Drug Delivery Systems Product Offerings
Table 84. Huarun 999 Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 85. Huarun 999 Key News & Latest Developments
Table 86. Haw Par Company Summary
Table 87. Haw Par Transdermal Drug Delivery Systems Product Offerings
Table 88. Haw Par Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 89. Haw Par Key News & Latest Developments
Table 90. Nichiban Company Summary
Table 91. Nichiban Transdermal Drug Delivery Systems Product Offerings
Table 92. Nichiban Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 93. Nichiban Key News & Latest Developments
Table 94. Mentholatum Company Summary
Table 95. Mentholatum Transdermal Drug Delivery Systems Product Offerings
Table 96. Mentholatum Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 97. Mentholatum Key News & Latest Developments
Table 98. Laboratoires Genevrier Company Summary
Table 99. Laboratoires Genevrier Transdermal Drug Delivery Systems Product Offerings
Table 100. Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue (US$, Mn) & (2018-2023)
Table 101. Laboratoires Genevrier Key News & Latest Developments
List of Figures
Figure 1. Transdermal Drug Delivery Systems Segment by Type in 2022
Figure 2. Transdermal Drug Delivery Systems Segment by Application in 2022
Figure 3. Global Transdermal Drug Delivery Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Transdermal Drug Delivery Systems Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Transdermal Drug Delivery Systems Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2022
Figure 8. By Type - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 9. By Application - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 10. By Type - Global Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 12. By Application - Global Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 14. By Region - Global Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 15. By Country - North America Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 16. US Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 20. Germany Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 21. France Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 28. China Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 32. India Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 34. Brazil Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Transdermal Drug Delivery Systems Revenue Market Share, 2018-2029
Figure 37. Turkey Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Transdermal Drug Delivery Systems Revenue, (US$, Mn), 2018-2029
Figure 41. Hisamitsu Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Mylan Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GSK Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Teve (Actavis) Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lohmann Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Teve (Actavis) Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Qizheng Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Endo Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Huarun 999 Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Haw Par Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Nichiban Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Mentholatum Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
